End-of-day quote
Other stock markets
|
||
- SEK | - |
02-20 | Isofol Medical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
02-20 | Isofol Medical AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2021 | 22.41M 2.07M 165M | Sales 2022 | 12.8M 1.18M 94.3M | Capitalization | 120M 11.05M 881M |
---|---|---|---|---|---|
Net income 2021 | -200M -18.49M -1.47B | Net income 2022 | -160M -14.79M -1.18B | EV / Sales 2021 | 49.7 x |
Net cash position 2021 | 378M 34.93M 2.78B | Net cash position 2022 | 187M 17.26M 1.38B | EV / Sales 2022 | -5.24 x |
P/E ratio 2021 |
-5.8
x | P/E ratio 2022 |
-0.75
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 62.57% |
Managers | Title | Age | Since |
---|---|---|---|
Petter Lindqvist
CEO | Chief Executive Officer | 72 | 01-08 |
Magnus Hurst
DFI | Director of Finance/CFO | 68 | 01-09 |
Roger Tell
CTO | Chief Tech/Sci/R&D Officer | 59 | 31/01/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lars Erik Lind
CHM | Chairman | 83 | - |
Sten Nilsson
BRD | Director/Board Member | 76 | 01-03 |
Alain Herrera
BRD | Director/Board Member | 74 | 31/12/17 |
1st Jan change | Capi. | |
---|---|---|
+5.48% | 71.19B | |
+12.55% | 9.3B | |
-13.75% | 5.01B | |
+42.38% | 4.47B | |
+4.51% | 3.96B | |
-19.05% | 2.41B | |
-28.72% | 2.23B | |
+11.13% | 2.02B | |
+6.53% | 1.69B |